CGEN (Compugen) Short Percentage of Float


CGEN Compugen Ltd CGEN
60 GF Score
Price $2.04
GF Value $5.24
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Compugen Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CGEN vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, Compugen's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Compugen Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Compugen's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Compugen's Short Percentage of Float falls into.


CGEN
60GF Score
Compugen Ltd CGEN
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Compugen (CGEN) Overvalued in 2026?

Based on GuruFocus' analysis, Compugen stock appears to be undervalued. The current stock price of $2.04 is trading 61.1% below its estimated GF Value™ of $5.24. GuruFocus considers Compugen to be Possible Value Trap.

Key valuation signals for CGEN:

  • Short Percentage of Float:
  • GF Value™: $5.24 vs. price of $2.04 (61.1% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the CGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Compugen Business Description

Other Exchanges CGEN:Israel
Address 26 Harokmim Street, Building D, Azrieli Center, Holon, ISR, 5885849
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
60GF Score

Get the complete analysis for CGEN

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.04
Price
$5.24
GF Value